In Brief
-
Wes Brown dies at 63
Brown developed stem-cell therapies for patients who suffered infections after receiving blood or bone marrow transplants.
-
Register for RAISE Health symposium
Register for the inaugural RAISE Health symposium, which will convene leaders in artificial intelligence for discussions on safe and responsible AI innovation.
-
Pump for kids’ failing hearts
A new type of surgically implanted pump that can support a child’s failing heart has passed the first stage of human testing in a Stanford Medicine-led trial.
-
Cell-based therapy for solid tumors
The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.
-
Stanford Medicine magazine on psychiatry
The new issue of Stanford Medicine magazine reports on emerging research and innovative treatments to improve mental health.
-
Biochemist Lubert Stryer dies at 86
Stryer made fundamental discoveries in fluorescence spectroscopy and vision, established structural biology at Stanford, and uplifted young scientists.
-
Shedding light on exercise’s effects
A Stanford Medicine-led effort to learn more about exercise’s molecular effects paints the broadest picture yet of why, in the health arena, sweat is king.
-
Studying neurodevelopmental disorders
Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.
-
Chuck Chan dies at 48
The Stanford Medicine researcher was known for his groundbreaking work and his generous spirit as a mentor and colleague.
-
New epilepsy target
Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going.